First, we compared protein levels between healthy donor-derived cells (the wild-type control) and NPC patient-derived cells (NPC1 mutant) and identified 46 differentially expressed proteins (annotated by protein database) whose levels differed more than twofold in NPC1 mutant cells compared to wild-type cells (Table 1). The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.